These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8032828)

  • 1. A simplified grading method of transitional cell carcinoma of the urinary bladder: reproducibility, clinical significance and comparison with other prognostic parameters.
    Schapers RF; Pauwels RP; Wijnen JT; Arends JW; Thunnissen FB; Coebergh JW; Smeets AW; Bosman FT
    Br J Urol; 1994 Jun; 73(6):625-31. PubMed ID: 8032828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological grading of transitional cell tumours of the bladder. Value of histological grading (WHO) in prognosis.
    Collan Y; Mäkinen J; Heikkinen A
    Eur Urol; 1979; 5(5):311-8. PubMed ID: 446506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative histopathology in the prognostic evaluation of patients with transitional cell carcinoma of the urinary bladder.
    Sasaki M; Sørensen FB; Fukuzawa S; Yamabe H; Olsen S; Yoshida O
    Cancer; 1993 Oct; 72(8):2470-83. PubMed ID: 8402464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent clinical, histological and quantitative prognostic factors in transitional-cell bladder tumours, with special reference to mitotic frequency.
    Lipponen PK; Eskelinen MJ; Jauhiainen K; Harju E; Terho R; Haapasalo H
    Int J Cancer; 1992 May; 51(3):396-403. PubMed ID: 1592531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of transitional cell bladder cancer: a multivariate prognostic score for improved prediction.
    Lipponen PK; Eskelinen MJ; Kiviranta J; Pesonen E
    J Urol; 1991 Dec; 146(6):1535-40. PubMed ID: 1942335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometry in comparison with mitotic index in predicting disease outcome in transitional-cell bladder cancer.
    Lipponen PK; Nordling S; Eskelinen MJ; Jauhiainen K; Terho R; Harju E
    Int J Cancer; 1993 Jan; 53(1):42-7. PubMed ID: 8416203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic comparison of proliferation markers and World Health Organization 1973/2004 grades in urothelial carcinomas of the urinary bladder.
    Mangrud OM; Gudlaugsson E; Skaland I; Tasdemir I; Dalen I; van Diermen B; Baak JP; Janssen EA
    Hum Pathol; 2014 Jul; 45(7):1496-503. PubMed ID: 24796506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder: clinical significance and comparison with other prognostic factors.
    Oosterhuis JW; Schapers RF; Janssen-Heijnen ML; Smeets AW; Pauwels RP
    Cancer; 2000 Jun; 88(11):2598-605. PubMed ID: 10861439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder.
    Bol MG; Baak JP; Buhr-Wildhagen S; Kruse AJ; Kjellevold KH; Janssen EA; Mestad O; Øgreid P
    J Urol; 2003 Apr; 169(4):1291-4. PubMed ID: 12629345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of tumour spread, grading and growth pattern as morphological predictive parameters in bladder carcinoma. A critical revision of the 1987 TNM classification.
    Angulo JC; Lopez JI; Flores N; Toledo JD
    J Cancer Res Clin Oncol; 1993; 119(10):578-93. PubMed ID: 8335677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classic prognostic factors, flow cytometric data, nuclear morphometric variables and mitotic indexes as predictors in transitional cell bladder cancer.
    Lipponen PK; Eskelinen MJ; Kiviranta J; Nordling S
    Anticancer Res; 1991; 11(2):911-6. PubMed ID: 2064350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of T1-2 GI-II transitional cell bladder cancer; evaluation by histoquantitative methods.
    Lipponen PK; Eskelinen MJ; Sotarauta M
    Scand J Urol Nephrol; 1991; 25(2):129-34. PubMed ID: 1871558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 2004 and 1973 World Health Organization grading systems and their relationship to pathologic staging for predicting long-term prognosis in patients with urothelial carcinoma.
    Cao D; Vollmer RT; Luly J; Jain S; Roytman TM; Ferris CW; Hudson MA
    Urology; 2010 Sep; 76(3):593-9. PubMed ID: 20381131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems.
    Oosterhuis JW; Schapers RF; Janssen-Heijnen ML; Pauwels RP; Newling DW; ten Kate F
    J Clin Pathol; 2002 Dec; 55(12):900-5. PubMed ID: 12461053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volume-corrected mitotic index and mitotic activity index in transitional cell bladder cancer.
    Lipponen PK; Eskelinen MJ
    Eur Urol; 1990; 18(4):258-62. PubMed ID: 2289518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The World Health Organization 1973 classification system for grade is an important prognosticator in T1 non-muscle-invasive bladder cancer.
    van de Putte EEF; Bosschieter J; van der Kwast TH; Bertz S; Denzinger S; Manach Q; Compérat EM; Boormans JL; Jewett MAS; Stoehr R; van Leenders GJLH; Nieuwenhuijzen JA; Zlotta AR; Hendricksen K; Rouprêt M; Otto W; Burger M; Hartmann A; van Rhijn BWG
    BJU Int; 2018 Dec; 122(6):978-985. PubMed ID: 29637669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis in bladder cancer as related to standard prognostic factors and prognosis.
    Lipponen PK; Aaltomaa S
    J Pathol; 1994 Aug; 173(4):333-9. PubMed ID: 7965393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
    Yang TB; Zeng FH; Sun ZQ
    Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volume corrected mitotic index (M/V index) in human bladder cancer; relation to histological grade (WHO), clinical stage (UICC) and prognosis.
    Lipponen PK; Collan Y; Eskelinen MJ; Pesonen E; Sotarauta M
    Scand J Urol Nephrol; 1990; 24(1):39-45. PubMed ID: 2320971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferating cell nuclear antigen cyclin in human transitional cell carcinoma.
    Hattori K; Uchida K; Akaza H; Koiso K; Nemoto R; Harada M
    Br J Urol; 1995 Feb; 75(2):162-6. PubMed ID: 7850319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.